Don’t forget treatment on World Hepatitis Day

The prohibitive price of hepatitis C virus medications will result in needless deaths if we don’t act now July 28, 2015 — On World Hepatitis Day 2015, as the World Health Organization (WHO) emphasizes prevention, the International Treatment Preparedness Coalition (ITPC) and Treatment Action Group (TAG) urge pharmaceutical companies and the governments of middle-income countries […]

Women in a village in Thies province, Senegal, are trained to become community health workers.

Representing Communities at the Global Fund Partner’s Forum

Rose Kaberia reports back from a Global Fund Partnership forum in Africa Representing ITPC-EA, I attended the Global Fund Partnership forum that took place last month in Addis Ababa, Ethiopia. We were one of the stakeholders who participated alongside other like-minded communities/networks of PLHIV from Africa, and Government representatives from the region. In preparation for […]

Photo of Othoman Mellouk, Intellectual Propery Expert for ITPC

Intellectual Property Expert and Activist Joins ITPC global

Dr. Othoman Mellouk has been appointed as the International Treatment Preparedness Coalition’s (ITPC) Intellectual Property and Access to Medicines Lead. Othoman’s role at ITPC includes coordinating a global consortium funded by UNITAID for three years from February 2015. The project seeks to remove intellectual property barriers that prevent people from accessing HIV treatment in middle-income […]

Picture of Julia Powell

ITPC appoints Strategic Communications Lead

The International Treatment Preparedness Coalition (ITPC) welcomes Julia Powell, a UK-based communications professional, to lead its global communication and campaign strategies. Communications will play a central part in helping ITPC achieve its ambitious goals, which were recently set out in its new strategic plan. ITPC’s three central goals are to: Create and increase demand for […]

ITPC West Africa Press Release: “Ebola is Major Factor Interrupting Antiretroviral Treatment to People Living with HIV in Sierra Leone”

MAY 29TH, 2015. FOR IMMEDIATE RELEASE  Today, human rights campaigners call for improved and regular access to HIV treatment in Sierra Leone, following the Ebola crisis. The International Treatment Preparedness Coalition – West Africa (ITPC-WA) joined forces with The Network of HIV Positives in Sierra-Leone to survey people living with HIV. They found that the […]

ITPC Welcomes Evidence for Early Start to HIV Treatment

The International Treatment Preparedness Coalition (ITPC) welcomes encouraging new evidence from an international study, Strategic Timing of AntiRetroviral Treatment, or START for short. “It is exciting to see that we now have data that provides concrete evidence of the clinical benefits of starting people early on HIV treatment,” explains Christine Stegling, Executive Director of ITPC. […]

Thousands of activists urge company to change its policies on eve of shareholder meeting

New York, May 5, 2015 — On the eve of pharmaceutical company Gilead Sciences’ annual shareholder meeting, thousands of people who have hepatitis C virus (HCV) and HCV/HIV coinfection, with their allies and physicians, have demanded that Gilead change its policies that deny access to treatment for millions of people in developing countries. “Gilead must […]

Civil Society Opposes Patent Application on HIV Drug Truvada® In a Bid to Stop Argentina From Paying 30 Times More Than Other Countries

The International Treatment Preparedness Coalition (ITPC) supports the patent pre-grant opposition that was filed on 13 April 2015 by the Fundación Grupo Efecto Positivo (FGEP) and the Argentinian Network of Positive People (Redar Positive). The patent was filed at Argentina’s patent office and challenges the validity of a patent application submitted by Gilead Sciences on […]

A Step Back for Millions of People with Hepatitis C

FOR IMMEDIATE RELEASE SEPTEMBER 19, 2014 A Step Back for Millions of People with Hepatitis C: Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham Hepatitis C Virus (HCV) Treatment: Gilead Sciences Voluntary License Under the pretext of increasing access to its hepatitis C treatment, the […]


Take Action

Sign ITPC’s petition to Gilead A recent decision by India’s Patent Office rejecting one of Gilead’s key patents for sofosbuvir is an important step for treatment activists. But Gilead is using every trick in the book to get the decision reversed, including lobbying the Indian Government. Sign our petition today to expand Hep C treatment!